Patents by Inventor Farheen AHMED

Farheen AHMED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NYVAC-based plasmodium malaria vaccine
    Patent number: 11013791
    Abstract: The disclosure generally provides a WRrNYVAC comprising multiple antigens from different stages of a malaria parasite (Plasmodium) life cycle, methods for producing them, immunogenic vaccine formulations comprising WRrNYVAC, such as P. vivax containing formulations (WRPvrNYVAC) and P. falciparum containing formulations (WRPfrNYVAC) and methods for the prevention and/or treatment of malaria infections and poxvirus infections.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: May 25, 2021
    Assignee: The Government of the United States, As Represented by the Secretary of the Army
    Inventors: Kevin D. Hauns, Farheen Ahmed, Saba Alemayehu
  • NYVAC-BASED PLASMODIUM MALARIA VACCINE
    Publication number: 20200147196
    Abstract: The disclosure generally provides a WRrNYVAC comprising multiple antigens from different stages of a malaria parasite (Plasmodium) life cycle, methods for producing them, immunogenic vaccine formulations comprising WRrNYVAC, such as P. vivax containing formulations (WRPvrNYVAC) and P. falciparum containing formulations (WRPfrNYVAC) and methods for the prevention and/or treatment of malaria infections and poxvirus infections.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 14, 2020
    Applicant: The Government of the United States of America as Represented by the Secretary of the Army
    Inventors: Kevin D. HAUNS, Farheen AHMED, Saba ALEMAYEHU
  • TSLP BINDING PROTEINS
    Publication number: 20170260266
    Abstract: The present disclosure relates to TSLP binding proteins that interact with particular residues of human full length TSLP, or contact particular regions of human full length TSLP. The invention also includes pharmaceutical compositions and medical uses of these TSLP binding proteins.
    Type: Application
    Filed: March 7, 2017
    Publication date: September 14, 2017
    Inventors: Farheen AHMED, Michelle Anne BARTHOLOMEW, Chun-Wa CHUNG, Pietro DELLA CRISTINA, Caroline J. DIMECH, Peter Joseph MORLEY, Rachana Shailesh SHAH
  • TSLP Binding Proteins
    Publication number: 20160264658
    Abstract: The present disclosure relates to TSLP binding proteins, such as anti-TSLP single variable domains, polynucleotides encoding such TSLP binding proteins, pharmaceutical compositions and kits comprising said TSLP binding proteins and methods of manufacture. The present invention also concerns the use of such TSLP binding proteins in the treatment of diseases associated TSLP signaling, such as asthma.
    Type: Application
    Filed: March 9, 2016
    Publication date: September 15, 2016
    Inventors: Farheen AHMED, Michelle Anne Bartholomew, Pietro Della Cristina, Caroline Dimech, Peter Morley, Rachana Shailesh Shah, Paula Tilling